SCHEMBL7098286

SCHEMBL7098286

COC(=O)[C@@H](N)Cc1cn(Cc2c(Cl)cccc2Cl)cn1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CPB2 Q96IY4 7/20 0.36
HPGD P15428 1/20 0.36
PTGS2 P35354 1/20 0.36
CPB1 P15086 3/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
TRHDE Q9UKU6 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6499762 0.87 KDM2B (0.41) ALDH1A1PTGS2MEN1KMT2AKDM4C
SCHEMBL7103533 0.86 CYP1A2 (0.41) ALDH1A1CPB2CPB1KDM4CTRHDE
SCHEMBL6527840 0.85 CDK5 (0.47) CYP3A4CYP2C9CYP2C19CPB2CPB1
SCHEMBL6069460 0.85 CDK5 (0.47) CYP3A4CYP2C9CYP2C19CPB2CPB1
Hydrochloric Acid SCHEMBL7356305 0.84 CDK5 (0.46) CYP3A4CYP2C9CYP2C19CPB2CPB1
Hydrochloric Acid SCHEMBL6527838 0.84 CDK5 (0.46) CYP3A4CYP2C9CYP2C19CPB2CPB1
Hydrochloric Acid SCHEMBL5997862 0.84 CDK5 (0.46) CYP3A4CYP2C9CYP2C19CPB2CPB1
Hydrochloric Acid SCHEMBL6527843 0.84 CDK5 (0.46) CYP3A4CYP2C9CYP2C19CPB2CPB1
Hydrochloric Acid SCHEMBL6529050 0.83 FNTA (0.40) ALDH1A1CYP3A4CYP2C9CYP2C19CPB2
Hydrochloric Acid SCHEMBL6531456 0.83 SMN1; SMN2 (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991619-B1 INHIBITORS OF ALPHA 4-BETA 1 MEDIATED CELL ADHESION TANABE SEIYAKU CO (JP) 2003-09-10 EP disclosed
US-20030130349-A1 Inhibitors of alpha 4beta1 mediated cell adhesion TANABE SEIYAKU CO., LTD. 2003-07-10 US disclosed
EP-0991619-A1 INHIBITORS OF $g(a) 4?$g(b) 1?MEDIATED CELL ADHESION TANABE SEIYAKU CO., LTD. (JP) 2000-04-12 EP disclosed
WO-1998058902-A1 INHIBITORS OF α4β1MEDIATED CELL ADHESION TANABE SEIYAKU CO., LTD. (JP) 1998-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130349-A1 Inhibitors of alpha 4beta1 mediated cell adhesion VCAM1, ICAM1, ITGB1 ALDH1A1 100/4885KDM4E 2802/4885CYP3A4 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.